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Favism, or “favic crisis,” is a potentially life-threatening acute
hemolysis elicited in carriers of low-activity glucose 6-phosphate
dehydrogenase (G6PD) variants by ingestion of raw faba bean
(Vicia faba L) (FB) seeds.1,2 In 2 surveys of hemolytic crises because
of favism in Sardinia in 948 children aged 2 to 12 years and
610 adults, hemolysis was elicited by raw beans in 94.4% and 97%
of all cases, respectively.3,4 Low-activity G6PD variants are the
Mediterranean variant (1% to 5% residual activity)2,5 predominantly
present in Sardinia and common inMediterranean andMiddle East
countries and in the Indian subcontinent,5 and other G6PD variants
common in China and the Far East.6 FBs are rich in proteins, starch,
fibers, vitamins, and minerals and are low in fat.7 FB seeds are
uniquely rich (5-14 g/kg wet weight) with the b-glucosides
vicine (V) and convicine (C),7,8 which generate the redox-active
aglycones divicine (D; 2,6-diamino-4,5-dihydroxypyrimidine)
and isouramil (I; 6-amino-2,4,5-trihydroxypyrimidine)1,9 upon
hydrolysis by the b-glucosidase very active in raw FBs.10,11
D/I share an identical mechanism of action and are considered
to be causative elements of favism.9-11 In isolated, oxygenated
red blood cells (RBCs), D/I generate semiquinoid free radicals12
that produce oxygen radicals and hydrogen peroxide,13 which
rapidly oxidize reduced NAD phosphate (NADPH), reduced glu-
tathione (GSH), thiol groups, and membrane lipids of RBCs10,11,14;
transform oxy-hemoglobin in ferrylhemoglobin, methemoglobin,
and hemichromes11,15-17; and release iron from hemoglobin
and ferritin.14 Although in D/I-treated G6PD-normal RBCs
GSH and NADPH are rapidly regenerated and oxidative modi-
fications reversed, no reversal occurs in D/I-treated G6PD-
deficient RBCs.10,11 Without the protective action of GSH and
NADPH, a chainof oxidativeeventsmayenhancephagocytic removal
of damaged RBCs.10,11 Indeed, RBCs isolated during hemolytic crisis
have shown early decrease of GSH and NADPH10,11; peroxidation
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of membrane lipids14; increase of hemichromes, aggregated
band 3,11,14-16 and intracellular calcium17; occurrence of rigid
“cross-bondedRBCs”11; and increasedphagocytic susceptibility.10,11,17
Balance studies between disappearance of RBCs and ap-
pearance of free hemoglobin in plasma and urine during
hemolytic crisis10,11 and evidence of massive erythrophagocytosis
at crisis apex18 have indicated that RBCs were largely removed
by extravascular hemolysis. A minor share of RBCs break down by
intravascular lysis resulting in occasional hemoglobinuria.2,4,10
A spontaneous mutant allele of vc gene in V. faba that induces
very low levels of V/C has been isolated from a Greek FB cultivar
(line 1268),19 leading to breeding of the low-V/C Divine cultivar
(vc-) with 0.16 g/kg wet weight V/C, compared with high-V/C
beans used here with 4.75 g/kg wet weight V/C.19
We show here that ingestion of large amounts of raw low-V/C
FBs (Divine cultivar) by hemizygous and heterozygous carriers
of low-activity G6PD (presumably G6PD-Mediterranean variant)
did not cause oxidative RBC damage and hemolysis. In pre-
liminary in vitro and ex vivo experiments, b-glucosidase–treated
extracts from high- and low-V/C raw FBs were used to determine
the potency to oxidize GSH in vitro and to challenge RBCs from
G6PD-normal and G6PD-deficient subjects ex vivo (Figure 1).
In vitro, in contrast to complete oxidation of GSH by high-V/C
FB extracts, oxidation by low-V/C FB extracts was marginal
(Figure 1A). In experiments with freshly isolated RBCs, high-V/C
FB extracts decreased GSH level reversibly in G6PD-normal
RBCs and irreversibly in G6PD-deficient RBCs (Figure 1B),
whereas extracts from low-V/C FBs did not modify GSH levels
either in G6PD-normal or G6PD-deficient RBCs (Figure 1C).
These results were instrumental to obtain ethical clearance for
in vivo testing of low-V/C FBs in G6PD-deficient subjects. Study
protocol was approved by Alghero Hospital ethical committee
(according to the Declaration of Helsinki), and informed consent
was provided by all G6PD-normal and G6PD-deficient subjects
(healthy adult hemizygous males and heterozygous females) of
Sardinian ancestry. Hemizygous males were identified as G6PD
deficient by quantitative assay of G6PD activity (,3% of normal
activity). Heterozygous females (0.5% to 37.2% of normal ac-
tivity) were sisters/daughters of G6PD-deficient males. None of
the G6PD-deficient subjects had ever eaten FBs in any form.
However, 1 or more close relatives (father, brother, uncle) had
favism at child age. G6PD-normal controls were healthy adult
subjects who had previously consumed high-V/C FBs without
any adverse reaction. G6PD-activitiy and hematological data of
all normal and G6PD-deficient subjects are shown in supple-
mental Tables 1-3 (available on the Blood Web site) and sum-
marized in supplemental Figure 1. ThreeG6PD-deficient subjects,
2 women (B.M. and S.R.P.) and 1 man (D.F.G.) (see supplemental
Tables 1-3) were silent carriers of b-thalassemia.
Selected early and sensitive indicators of oxidative damage
prodromal of extravascular and intravascular hemolysis were
analyzed time dependently in hemizygous and heterozygous
G6PD-deficient subjects after ingestion of 500 g low-V/C raw FB
seeds per 70 kg body weight (ie, 5-10 times the amount of an
average FB meal). G6PD-normal subjects ingested the same
amount of high-V/C raw FBs. As shown in Figure 2, in G6PD-
normal subjects, some sensitive early indicators of RBC oxidative
damage were transitorily altered, showing a short-term revers-
ible decrease in GSH levels and RBC deformability, and in-

























































Figure 1. Effect of extracts fromhigh- or low-V/C FBs on theGSH levels in a cell-free system and in isolatedG6PD-normal andG6PD-deficient RBCs. Fresh FBs with high-
V/C (average content of V/C in raw seeds: 4.75 g/kg wet weight) and with low-V/C (Divine cultivar, average content of V/C in raw seeds: 0.16 g/kg wet weight), were grown and
collected at Institut National de la Recherche Agronomique, Dijon, France. FB seeds were immediately flash-frozen after harvest and kept on dry ice until usage. Thirty minutes
before use, FBs were thawed, dehulled, suspended in degassed, nitrogen-flushed isotonic phosphate-buffered saline (PBS) at 50% weight-to-volume ratio, and homogenized in
the cold in a nitrogen atmosphere with a high-speedGVA2-type homogenizer (KrupsGmbH,Offenbach amMain, Germany). The slurry was centrifuged for 10minutes at 15 000g
and 4°C, and V/C assayed in the resulting extracts as indicated19 with pure vicine (Serva, Heidelberg, Germany) as a standard. Before starting incubations, the FB extracts were
treated with 5mg/mLb-glucosidase from almonds (Sigma, St. Louis, MO) during 60minutes at 37°C to enhance the generation of the active compoundsD and I from the inactive
V/C. (A) Effect of high-V/C and low-V/C FB extracts on GSH oxidation in a cell-free system. GSH was dissolved at 2.5 mM (final concentration) in PBS-glucose, and FB extract
added. The final concentration of V/C in the test system was 2.5 mM or 0.1 mM for high- and low-V/C, respectively. In control samples, PBS-glucose was added instead of the
FB extract. The test solutions were incubated at 37°C. The GSH concentration was assessed time dependently as indicated.23 Mean values 6standard deviation (SD) of
3 independent experiments. (B) Effect of high-V/C FB extracts on GSH oxidation in isolated RBCs from G6PD-normal and G6PD-deficient subjects. Washed RBCs freshly
isolated from hemizygous G6PD-deficient (open squares) and G6PD-normal (filled squares) subjects were resuspended in PBS-glucose at a hematocrit of 50%, supplemented at
time 0 with extracts from high-V/C FBs at 2.5 mMV/C (final concentration) and incubated at 37°C. The GSH concentration in RBCs was assessed time dependently as indicated.23
Mean values6 SD of 3 independent experiments from 3 different subjects. (C) Effect of low-V/C FB extracts on GSH oxidation in isolated RBCs from G6PD-normal and G6PD-
deficient subjects. Washed RBCs freshly isolated from hemizygous G6PD-deficient (open circles) and G6PD-normal (filled circles) subjects were resuspended in PBS-glucose
at a hematocrit of 50%, supplemented at time 0 with extracts from low-V/C FBs at 0.1 mM V/C (final concentration), and incubated at 37°C. The GSH concentration in RBCs
was assessed time dependently as indicated.23 Mean values 6 SD of 3 independent experiments from 3 different subjects.
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Figure 2. Time-dependent behavior of indicators of RBC oxidative damage in G6PD-normal subjects, G6PD-deficient heterozygous females, and G6PD-deficient
hemizygousmales after ingestion of high-V/C FBs (normal subjects) and low-V/C FBs (G6PD-deficient subjects).G6PD-normal controls (left panels; N5 9), G6PD-deficient
heterozygous subjects (central panels, N5 7), and hemizygous subjects (right panels, N5 7) ingested 500 g/70 kg body weight freshly homogenized raw dehulled FBs at time 0.
The G6PD-normal subjects ingested high-V/C FBs (average content of V/C in raw seeds: 4.75 g/kg wet weight) and low-V/C FBs (Divine cultivar, average content of V/C in raw
seeds: 0.16 g/kg wet weight); the heterozygous and hemizygous G6PD-deficient subjects ingested low-V/C FBs. Blood was drawn via a cubital vein catheter within the Alghero
Hospital setting under constantmedical supervision immediately before the FBmeal (time 0) and during the whole duration of the study as indicated. Indicators of RBC oxidative
damage were measured time dependently as indicated: (A) intracellular GSH23; (B) RBC deformability by RBC filtration24; (C) membrane-bound hemichromes by luminescence-
based heme quantification24; (D) membrane bound 4-hydroxynonenal (HNE) conjugates by fluorescence-activated cell sorting (FACS)25; (E) membrane-bound complement
fragments C3c by FACS24; (F) membrane-bound autologous immunoglobulin G (IgG) by FACS.24 Mean values 6 SD of 9 or 7 subjects as indicated. Data analyzed by Student
t test. Symbols (*, #) indicate significantly different from time 0 value.**P, .005; *P, .01; #P, .05. For hematological data, see supplemental Tables 1-3 and supplemental Figure 1.
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(a lipoperoxidation product that triggers erythrophagocytosis
when conjugated to membrane proteins20), in membrane-
bound complement C3c fragments and autologous immuno-
globulin. Modifications were generally modest, although
occasionally significant, but fully reversible. Baseline levels were
attained in all parameters after 8 to 10 hours from FB ingestion. By
contrast, none of indicators of RBC oxidative damage and
prodromal signals for phagocytic removal were significantly
modified by low-V/C FB meal in any of hemizygous or het-
erozygous G6PD-deficient subjects (Figure 2). None of he-
molysis indicators (ie, number of RBCs, hematocrit, RBC
hemoglobin, serum haptoglobin, and indirect bilirubin) were
significantly modified at any time during 2 days follow-up after
low-V/C FB meal either in G6PD-normal or in G6PD-deficient study
participants (supplemental Tables 1-3 and supplemental
Figure 1). In sum, data shown in Figure 2, supplemental
Table 1-3, and supplemental Figure 1 indicate that no RBC
damage or intravascular hemolysis was taking place in any
G6PD-deficient subject after consumption of low-V/C FBs. In
normal subjects, none of the tested parameters were modified after
ingestion of low-V/C FBs (not shown).
The present study was performed on a small number of G6PD-
deficient subjects that never consumed FBs before. Both ele-
ments may affect the study’s strength. Yet, lack of any sign of
oxidative RBC damage and hemolysis after ingestion of large
amounts of raw high-V/C FBs may allow the conclusion that
low-V/C FBs can be safely consumed by carriers of low-activity
G6PD variants. Since;8000 to 10000 years BC, FBs were cultivated
and became a staple food in several semiarid regions.21 FBs are a
hemolytic risk for .400 million G6PD-deficient men and women
worldwide.5 Availability of low-V/C FBs with high protein, minerals,
vitamins, and low fat content, well adapted to semiarid regions,22 may
have a positive impact in agriculture and human nutrition particularly
in poor countries hit by ever-increasing severe drought periods.
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